Publication | Closed Access

Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine★

VaccinationCancer ImmunosurveillanceBreast Cancer PatientsImmunologyGm-csf Vaccine★Therapeutic VaccineAntigen ProcessingT Cell ImmunityCd4 T Cell ResponsesBreast CancerHer2/neu PeptideImmunotherapyMedicineRadiation Oncology